Sigrid Vorobjov

Mrs. Sigrid Vorobjov

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AUAnneli Uusküla
Anneli Uusküla
MRMait Raag
Mait Raag
SVSigrid Vorobjov
Sigrid Vorobjov
KRKristi Rüütel
Kristi Rüütel
ALAlexandra Lyubimova
Alexandra Lyubimova
RHRobert. Heimer
Robert. Heimer
This study seeks to identify the prevalence of, and risk factors associated with, non-fatal overdose among people currently injecting drugs (PWID) in St. Petersburg (Russia) and in Kohtla-Järve (Estonia). Five hundred eighty-eight study participants in Kohtla-Järve (in 2012) and 811 in St. Petersburg (in 2012–2013) were recruited using respondent driven sampling for interviewing and HIV testing. Three-quarters (76 %) of the current PWID were male. Participants from St. Petersburg were older (mean age 32.1 vs. 29.6 years, p < 0.0001) and reported a longer average duration of injecting drugs (mean duration: 13.3 vs. 10.9 years, p < 0.0001). Main drugs injected were opioids (fentanyl in Kohtla-Järve, heroin in St Petersburg). HIV prevalence was 63 % (95 % CI 59–67 %) in Kohtla-Järve and 56 % (95 % CI 52–59 %) in St. Petersburg. Two thirds of the PWID in Kohtla-Järve and St. Petersburg reported ever having experienced a drug overdose involving loss of consciousness or stopping breathing. In Kohtla-Järve, 28 % (95 % CI 24–31 %) of participants and, in St Petersburg, 16 % (95 % CI 14–19 %) of participants reported an overdose within the previous 12 months. Characteristics of injection drug use practice (longer duration of injection drug use, main drug injected), correlates of high-risk injection behaviour (higher injecting frequency, sharing), and problem alcohol use were associated with the risk of overdose within the previous 12 months. The significant factors effects did not differ between the sites. PWID are at high risk for overdose. Effective overdose prevention efforts at the public health scale are therefore warranted.

1 January 2009 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
SVSigrid Vorobjov
Sigrid Vorobjov
AUAnneli Uusküla
Anneli Uusküla
KAKatri Abel-Ollo
Katri Abel-Ollo
ATAve Talu
Ave Talu
KRKristi Rüütel
Kristi Rüütel
DJDon C Des Jarlais
Don C Des Jarlais
Both syringe exchange programs (SEPs) and pharmacy sales of syringes are available in Estonia, though the current high incidence and high prevalence of HIV among injection drug users (IDUs) in Tallinn, Estonia requires large-scale implementation of additional harm reduction programs as a matter of great urgency. The aims of this report were to compare risk behavior and HIV infection and to assess the prevention needs among IDUs who primarily use pharmacies as their source of sterile syringes with IDUs who primarily use SEPs in Tallinn.

1 March 2013 in International Journal of Drug Policy
Verified
Journal Article
Closed access
SVSigrid Vorobjov
Sigrid Vorobjov
DJDon C. Des Jarlais
Don C. Des Jarlais
KAKatri Abel-Ollo
Katri Abel-Ollo
ATAve Talu
Ave Talu
KRKristi Rüütel
Kristi Rüütel
AUAnneli Uusküla
Anneli Uusküla

1 November 2005 in Maturitas
Verified
Journal Article
Closed access
SVSigrid Vorobjov
Sigrid Vorobjov
SHSirpa-Liisa Hovi
Sirpa-Liisa Hovi
PVPiret Veerus
Piret Veerus
HPHeti Pisarev
Heti Pisarev
MRMati Rahu
Mati Rahu
EHElina Hemminki
Elina Hemminki

18 November 2009 in Journal of Urban Health
Verified
Journal Article
Closed access
PDF file
SVSigrid Vorobjov
Sigrid Vorobjov
AUAnneli Uusküla
Anneli Uusküla
KAKatri Abel-Ollo
Katri Abel-Ollo
ATAve Talu
Ave Talu
DJDon Des Jarlais
Don Des Jarlais

1 June 2012 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
SVSigrid Vorobjov
Sigrid Vorobjov
AUAnneli Uusküla
Anneli Uusküla
DJDon C. Des Jarlais
Don C. Des Jarlais
KAKatri Abel-Ollo
Katri Abel-Ollo
ATAve Talu
Ave Talu
KRKristi Rüütel
Kristi Rüütel